Skip to content

Maze Therapeutics, Inc.

MAZE · XNAS

CIK 1842295fmd_0PRN2Y3XCV4N3WSPWJHRMWCHNNManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2024 to Sep 30, 2026, 11 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading